Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase NA 8Phase 1/2 4Phase EARLY_PHASE1 3Phase 2/3 3Phase 1 3Phase 4 1

Status

Completed 15Recruiting 14Terminated 5Unknown 4Active not recruiting 4Not yet recruiting 1

Sponsor Class

INDUSTRY 2OTHER_GOV 1OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 4

Conditions

Carcinoma, Non-Small-Cell Lung 72Breast Neoplasms 63Neoplasms 59Leukemia, Myeloid, Acute 58Multiple Myeloma 52Colorectal Neoplasms 48Lymphoma 46Stomach Neoplasms 43Recurrence 43Carcinoma, Hepatocellular 43Pancreatic Neoplasms 40Neoplasm Metastasis 39Melanoma 34Prostatic Neoplasms 33Leukemia 30Lymphoma, Non-Hodgkin 27Lymphoma, B-Cell 27Lung Neoplasms 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Glioblastoma 24Ovarian Neoplasms 23Lymphoma, Large B-Cell, Diffuse 21Esophageal Neoplasms 21Carcinoma, Renal Cell 20Myelodysplastic Syndromes 19Leukemia, Lymphocytic, Chronic, B-Cell 19Hematologic Neoplasms 19Colonic Neoplasms 19Head and Neck Neoplasms 18Lymphoma, Mantle-Cell 17

Interventions

TQ-B3525 1Ashwagandha 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Unknown × Osteosarcoma × Clear all
NCT04886765 2021-05-14

A Study to Evaluate the Safety and Efficacy of ALMB-0168 in Patients With Osteosarcoma

AlaMab Therapeutics (Shanghai) Inc.

Phase 1/2 Unknown
238 enrolled
Sarcoma

Osteosarcoma

NCT04690725 2020-12-31

TQBSP

Peking University People's Hospital

Phase 1/2 Unknown
29 enrolled
Sarcoma

Chondrosarcoma, Sarcoma, Ewing, Osteosarcoma

NCT03676985 2018-09-26

A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Limited Stage of High-grade Osteosarcoma

Lee's Pharmaceutical Limited

Phase 1/2 Unknown
15 enrolled
Sarcoma

Osteosarcoma

NCT00689195 2011-06-23

OSCAT

Tata Memorial Hospital

Phase 1/2 Unknown
24 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡